Eagle Genomics joins forces with global food nutrition giant Cargill
Global food nutrition gamechanger Cargill and Cambridge-based Eagle Genomics have agreed a multi-year platform engagement to enable the digital transformation of microbiome and life sciences R & D across the Minneapolis company’s international territories.
The deployment of the Eagle Genomics e[datascientist] platform will initially enable Cargill’s Health Technologies business to organise and synthesise additional insights from microbiome data amassed by the company over the past decade.
“By revealing relationships between microbiome data entities and relevant multi-omics data, the platform will further enable Cargill to advance our understanding of the complex association between the microbiome and digestive and immune health in humans and animals,” said Mike Johnson, marketing director, Cargill Health Technologies.
“Healthy animals, healthy people and a healthy planet are all interconnected,” Johnson explained. “With the advanced knowledge and insights we anticipate generating from our microbiome data, the e[datascientist] will allow us to effectively build on our existing suite of health solutions and bring more relevant products to market in this exciting area of functional food.”
With the capabilities to manage, explore and interpret life sciences data beyond the microbiome, the Eagle Genomics platform will ultimately allow Cargill to digitally reinvent its biological research activities to bring innovative products to customers, faster.
With a particular focus on the microbiome, (the populations of bacteria, viruses and fungi which coexist in our bodies, in the environment and which make up the majority of life on earth), Eagle Genomics is accelerating advances in the fields of sustainable agriculture and functional food.
The Eagle Genomics e[datascientist] platform applies AI, a unique data valuation engine and pioneering visualisation to navigate and reveal novel relationships between data entities at microbiomical scale.
Anthony Finbow, CEO at Eagle Genomics said: “We are delighted to be enabling Cargill to explore microbiome data for food and digestive health, an area which we believe will be transformed by microbiome discovery over the next decade. We look forward to a future of industry-disrupting food and nutraceutical products for humans and animals, informed by our platform.”
Eagle Genomics’ award-winning AI augmented knowledge discovery platform, the e[datascientist], is revolutionising how scientists conduct life sciences research and is bridging the gap between data and new insights in a rapid, systematic and traceable way.
It puts data science at the fingertips of biologists to drastically reduce time and cost of research, enabling customers to achieve radical productivity improvements and true data driven discovery.
Cargill started life 154 years ago in a single grain elevator in Iowa and now employs 160,000 professionals in 70 countries; it draws together the worlds of food, agriculture, nutrition and risk management.
The business helps farmers grow more, connecting them to broader markets, and is continuously developing products that advance nutrition, food safety and sustainability. It also helps all its partners innovate and manage risk.